h5-index is the h-index for articles published in the last 5 complete years. It is the largest number h such that h articles published in 2014-2018 have at least h citations each.hide
h5-median for a publication is the median number of citations for the articles that make up its h5-index.hide
Title / AuthorCited byYear
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
M Ng, T Fleming, M Robinson, B Thomson, N Graetz, C Margono, ...
The Lancet 384 (9945), 766-781
73712014
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
CT Ruff, RP Giugliano, E Braunwald, EB Hoffman, N Deenadayalu, ...
The Lancet 383 (9921), 955-962
24592014
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
RS Herbst, P Baas, DW Kim, E Felip, JL Pérez-Gracia, JY Han, J Molina, ...
The Lancet 387 (10027), 1540-1550
23942016
Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
VL Feigin, MH Forouzanfar, R Krishnamurthi, GA Mensah, M Connor, ...
The Lancet 383 (9913), 245-255
21122014
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ...
The Lancet 388 (10053), 1659-1724
20262016
Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect
CG Victora, R Bahl, AJD Barros, GVA França, S Horton, J Krasevec, ...
The Lancet 387 (10017), 475-490
19182016
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
L Liu, S Oza, D Hogan, J Perin, I Rudan, JE Lawn, S Cousens, C Mathers, ...
The Lancet 385 (9966), 430-440
18132015
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19· 2 million participants
NCD Risk Factor Collaboration
The Lancet 387 (10026), 1377-1396
17222016
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
M Naghavi, H Wang, R Lozano, A Davis, X Liang, M Zhou, SE Vollset, ...
LANCET 385 (9963), 117-171
16402015
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ...
The Lancet 386 (9995), 743-800
15662015
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
JE Rosenberg, J Hoffman-Censits, T Powles, MS van der Heijden, ...
The Lancet 387 (10031), 1909-1920
15282016
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study
VM Cao-Lormeau, A Blake, S Mons, S Lastère, C Roche, ...
The Lancet 387 (10027), 1531-1539
14342016
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
M Goyal, BK Menon, WH van Zwam, DWJ Dippel, PJ Mitchell, ...
The Lancet 387 (10029), 1723-1731
14202016
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
P Cortazar, L Zhang, M Untch, K Mehta, JP Costantino, N Wolmark, ...
The Lancet 384 (9938), 164-172
14162014
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
C Allemani, HK Weir, H Carreira, R Harewood, D Spika, XS Wang, ...
The Lancet 385 (9972), 977-1010
13572015
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
C Robert, A Ribas, JD Wolchok, FS Hodi, O Hamid, R Kefford, JS Weber, ...
The Lancet 384 (9948), 1109-1117
13252014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
DW Lee, JN Kochenderfer, M Stetler-Stevenson, YK Cui, C Delbrook, ...
The Lancet 385 (9967), 517-528
13202015
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
A Rittmeyer, F Barlesi, D Waterkamp, K Park, F Ciardiello, J von Pawel, ...
The Lancet 389 (10066), 255-265
13042017
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4· 4 million participants
NCD Risk Factor Collaboration
The Lancet 387 (10027), 1513-1530
12982016
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
CS Fuchs, J Tomasek, CJ Yong, F Dumitru, R Passalacqua, C Goswami, ...
The Lancet 383 (9911), 31-39
12912014
1 - 20
Dates and citation counts are estimated and are determined automatically by a computer program.